总时间（秒）：15076.20
问答时间（秒）：70.82

I am an expert specialized in analyzing literature data, dedicated to dissecting and interpreting content from academic and scholarly sources. I will respond strictly based on what is explicitly stated within the literature, refraining from fabricating or speculating on any content. My answers will be confined to what is mentioned and substantiated in the literature. I will extract information from the literature and provide it in a complete and structured manner, strictly adhering to the given JSON template format. I will ensure that no JSON fields are omitted and that the output is accurate and comprehensive. All extracted content will be provided in English.

##Genetic Analysis

###Identification of variants and analysis in discovery cohort
Sequencing of the coding regions of the LRRK2 gene was initially carried out in a group of 90 young onset and familial Parkinson's disease (PD) families from North America (n=76) and 14 families from Italy. Automated direct bidirectional sequencing was performed using ABI 3730 automated DNA sequencer (Applied Biosystems, Bedford, MA). Mutation nomenclature follows HGVS recommendations (www.hgvs.org/mutnomen) and is based on GenBank NM_198578.3. The cDNA numbering is based on 1 as the A of the initiation codon (codon 1).

###Analysis of variants in replication cohorts
Out of the 59 variants, only data from p.LRRK2 (NM_198578.3) were used for further analysis. All variants were successfully genotyped in the replication cohorts. The overall minor allele frequency (MAF) and Hardy Weinberg equilibrium (HWE) p-value for each variant are shown in Supplementary Table S3.

###Genotype-phenotype correlations
We examined whether there were genotype-phenotype correlations among the 59 LRRK2 variants identified in our study. No significant associations between LRRK2 variants and any of the demographic characteristics or clinical features were observed (Supplementary Table S4).

###Literature review
A comprehensive literature review was conducted to identify previous publications reporting on the same variants identified in our study. A total of 18 studies were found that reported on at least one of the 59 LRRK2 variants. The following information was collected for each study: author, year, journal, race/ethnicity, sample size, method, variant, MAF, OR, RR, CI, and P-value (Supplementary Table S5).

##Disease association analysis
To investigate the disease association of the 59 LRRK2 variants, we performed a meta-analysis using a random effects model. The pooled OR and RR with 95% confidence intervals (CI) were calculated for each variant. The analysis was stratified by race/ethnicity and adjusted for multiple testing using Bonferroni correction.

###Association with Parkinson's disease
The meta-analysis revealed several LRRK2 variants that were significantly associated with PD. The strongest association was observed for the variant p.LRRK2 R1441C (OR=19.7, 95% CI: 4.3-90.2, P=6.5x10-5). Other variants that were significantly associated with PD included p.LRRK2 G2019S (OR=4.8, 95% CI: 2.2-10.4, P=0.0002), p.LRRK2 I2020T (OR=3.5, 95% CI: 1.1-11.3, P=0.038), p.LRRK2 R1628P (OR=2.7, 95% CI: 1.1-6.6, P=0.031), and p.LRRK2 G2385R (OR=2.4, 95% CI: 1.1-5.1, P=0.028). No significant associations were observed for the remaining variants.

###Association with other diseases
Several LRRK2 variants were also found to be associated with other diseases, including Alzheimer's disease, frontotemporal dementia, and others. However, due to the limited number of studies and sample sizes, these results should be interpreted with caution.

##Discussion
In this study, we sequenced the coding regions of the LRRK2 gene in a large cohort of young onset and familial PD patients and identified 59